News

Promising results from a phase 2 study of CPL'36, a novel PDE10A inhibitor, for acute schizophrenia exacerbation was presented at the APA annual meeting.

Research from the 2025 APA Annual Meeting reveals a strong link between borderline personality disorder and problematic internet use, highlighting impulsivity and compulsivity in affected individuals.

Our board members are presenting at this year's APA Annual Meeting. Be sure to check out their sessions!

The Osheroff v. Chestnut Lodge case had a transformative impact on psychiatric practices and the evolving relationship between science and religion.

New analyses reveal valbenazine (Ingrezza) significantly enhances quality of life and functional outcomes for patients with tardive dyskinesia, supporting its long-term efficacy.

Psychiatrists can leverage media to reshape mental health narratives, combat misinformation, and engage with the public, in a way that fosters open conversations and reduces stigma.

Mental health professionals should navigate media engagement by upholding ethical standards, ensuring informed consent, and combating misinformation to promote public awareness.

Uncertainty fuels anxiety, yet knowing outcomes—even grim ones—can bring relief.

Check out this year's Gerald F. Berlin Prize winner!

Badr Ratnakaran, MBBS, Psychiatric Times' new Climate Change Section Editor, explores the intersection of climate change and mental health, highlighting the urgent need for awareness and support in clinical practice.

"And I feel closer to him than 50 minutes should allow, a puzzled sensation, I’ve known him all my life..."

Effective diagnosis and treatment of comorbid disorders in patients with bipolar enhance care and lead to more optimal mental health outcomes.

Brigitte Robertson, MD, shares information on innovative, genetically targeted treatments for alcohol use disorder, aiming to personalize care and improve patient outcomes.

Newron Pharmaceuticals launches pivotal ENIGMA-TRS trials for evenamide, targeting treatment-resistant schizophrenia with promising efficacy and safety outcomes.

What is the hidden mental health struggles of affluent youth? In this Tales From the Clinic article, we reveal how wealth can contribute to anxiety, depression, and substance misuse.

Discover the unique approaches to treating sleep disorders in children vs adults, highlighting effective behavioral strategies.

May is American Stroke Month. Here, you can find important information about recognizing the signs of the stroke to share with patients.

Combination therapy of TMS and ketamine could enhance brain perfusion and neuroplasticity.

Experts reflect on health, justice, and personal experiences in today's turbulent landscape.

Stay informed with this week's highlights, including more on dementia prevention, a treatment for alcohol use disorder, National Nurses Week, and finding joy.

Research reveals that IV haloperidol and ziprasidone are safe for treating delirium in patients that are critically ill, showing minimal impact on QTc intervals.

Awais Aftab, MD, explores the many aspects of psychiatry through engaging interviews that challenge traditional views and advocate for a more inclusive dialogue. Check out this review of his new book.

Let's look at the intersection of history, identity, and mental health through personal reflections and significant events that shape our lives today.

Adial Pharmaceuticals advances its treatment for alcohol use disorder, AD04, with FDA meetings and promising genetic insights for targeted therapy.

This critical analysis of recent ADHD coverage challenges misconceptions about treatment, emphasizing the need for a comprehensive approach to mental health.

The therapeutic alliance in psychiatry: enhancing patient engagement and treatment outcomes through effective communication and collaboration.

Check out this reflective analysis of a notable graduation speech and its personal implications.

Learn more about the latest advancements in schizophrenia treatment and the ongoing battle against stigma during Mental Health Awareness Month.

Explore the ethical complexities of euthanasia and assisted suicide through a philosophical lens.

This article is sponsored by Otsuka America Pharmaceutical, Inc. and Lundbeck, for which Dr. Ilan Melnick is a paid consultant.